View Latest Medical and Pharma Bids and Tenders

Supply of Medicine and Medical / Surgical equipments : Anti D.(Rho) Immunoglobulin (Human)\nInjection 300microgam in 1.5ml\nampoule/vial\nAnti D. (Rho) Immunoglobulin injection BP\nEach colourless glass ampoule or vial to\ncontain liquid or freeze dried preparation\ncontaining 300mcg (1500 IU) of Anti D (Rho)\nImmunoglobulin (Human)obtained from plasma\nor serum of D-negative donors who have been\nimmunized against the Rhesus D-antigen for\nintramuscular injection.\nOR\nEach colourless glass ampoule or vial to\ncontain liquid or freeze dried preparation\ncontaining 300mcg (1500 IU) of Anti D (Rho)\nImmunoglobulin (Monoclonal) derived from\nHeterohybridoma for intramuscular injection.\nNote:\n1.The volume of ampoule/vial can be up to\nmaximum of 2ml.\n2. This injection should be stable for a\nminimum of 24 months when stored within the\ntemperature range of 2'C - 8'C. Do not freeze.\n3.Each consignment should have a minimum\nremaining shelf life of 75% at the time of\nreceiving the consignment at MSD.\n4. Manufacturer should also conform that the\nproduct offered is free from Hepatitis B virus\nand Hepatitis C virus.\n5. The product should be protected from light\nby suitable packaging.\n6. Each ampoule/vial should be labelled\naccordingly.\nPacking : One vial etc .

Supply of Medicine and Medical / Surgical equipments : Human Immunoglobulin for intravenous use\n1g vial\nNormal immunoglobulin for intravenous use\nBP,1g Vial.\nEach vial to contain 1g of liquid or freeze-dried\npreparation of Normal Immunoglobulin BP for\nintravenous use. The immunoglobulin should\nbe mainly immunoglobulin Ig G and contain\nonly trace amount of Ig A.\nNote:\n1.This product should be stable for 02 years\nwhen stored under storage condition stipulated\nby the manufacturer.\n2. Each consignment should have a minimum\nremaining shelf life of 75% at the time of\nreceiving the consignment at MSD.\n3. Tenderers should submit detail specification\nof the product offered by them.\n4. The product should ensure combination of at\nleast two independent and complementary viral\ninactivation/reduction steps recommended by\nWHO.\n5. The product should be certified as free from\nHIV and hepatitis B and C viruses.\n6. Each vial should be labelled accordingly.\nPacking : one vial etc .

Supply of Medicine and Medical / Surgical equipments : Antirabies Human Immunoglobulin 300 I.U. etc .

Supply of Medicine and Medical / Surgical equipments : Antitetanus Human Immunoglobulin 250IU etc .